Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.43B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Dianthus Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −18 vs. Q3 2022
- Shares held
- 28.1M
- −18.5M (−39.6%) vs. Q3 2022
- Total value
- $11.1M
- −$54.6M (−83.1%) vs. Q3 2022
- New holders
- 7
- 16 more added
- Sold out
- 25
- 15 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.43B |
| Q1 2026 | 241 | $5.37B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.85B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $859.0M |
| Q2 2024 | 74 | $769.0M |
| Q1 2024 | 76 | $784.0M |
| Q4 2023 | 39 | $109.9M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $70.5M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.6M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $423.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $2.67M | 1.14% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $1.37M | 0.17% | 00.0% | Unchanged |
| Alphabet Inc. | 3,339,138 | $1.34M | 0.08% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,000,000 | $1.19M | 0.05% | −2,359,000−44.0% | Reduced |
| Millennium Management LLC | 2,313,552 | $914.0K | 0.00% | +218,210+10.4% | Added |
| Vanguard Group Inc | 1,964,238 | $775.9K | 0.00% | +8060.0% | Added |
| Adage Capital Partners GP, L.L.C. | 868,650 | $343.1K | 0.00% | +50,000+6.1% | Added |
| Renaissance Technologies LLC | 587,922 | $232.0K | 0.00% | +183,071+45.2% | Added |
| Laurion Capital Management LP | 582,300 | $230.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 463,036 | $182.9K | 0.00% | −274,851−37.2% | Reduced |
| Hellman Jordan Management Co Inc | 441,125 | $174.0K | 0.30% | +259,161+142.4% | Added |
| Integral Health Asset Management, LLC | 416,000 | $164.3K | 0.04% | +39,000+10.3% | Added |
| Geode Capital Management, LLC | 357,690 | $141.0K | 0.00% | +7,254+2.1% | Added |
| Bleichroeder LP | 346,631 | $136.9K | 0.03% | −137,769−28.4% | Reduced |
| RBF Capital, LLC | 341,422 | $135.0K | 0.01% | −30,000−8.1% | Reduced |
| Harvard Management Co Inc | 332,610 | $131.4K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 250,500 | $98.9K | 0.00% | −36,900−12.8% | Reduced |
| Bessemer Group Inc | 237,292 | $94.0K | 0.00% | +150.0% | Added |
| Bridgeway Capital Management, LLC | 212,200 | $83.8K | 0.00% | +65,000+44.2% | Added |
| Credit Suisse AG | 193,500 | $76.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 186,125 | $73.5K | 0.00% | +55,066+42.0% | Added |
| Leonteq Securities AG | 180,000 | $71.1K | 0.00% | +180,000 | New |
| Harbor Capital Advisors, Inc. | 160,912 | $63.6K | 0.06% | −3,441−2.1% | Reduced |
| Dimensional Fund Advisors LP | 152,984 | $60.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 139,207 | $55.0K | 0.00% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 129,395 | $47.0K | 0.00% | +129,395 | New |
| Acadian Asset Management LLC | 120,798 | $46.0K | 0.00% | +25,756+27.1% | Added |
| Northern Trust Corp | 86,611 | $34.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 79,703 | $31.5K | 0.00% | +64,288+417.0% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 75,806 | $29.9K | 0.00% | −10,825−12.5% | Reduced |
| Cheyne Capital Management (UK) LLP | 47,170 | $18.6K | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 38,059 | $15.0K | 0.00% | −73,702−65.9% | Reduced |
| Tower Research Capital LLC (TRC) | 38,808 | $15.0K | 0.00% | +26,219+208.3% | Added |
| Engineers Gate Manager LP | 34,090 | $13.5K | 0.00% | +34,090 | New |
| Fiduciary Trust Co | 30,555 | $12.1K | 0.00% | 00.0% | Unchanged |
| National Asset Management, Inc. | 28,000 | $11.1K | 0.00% | +28,000 | New |
| Charles Schwab Investment Management Inc | 27,369 | $10.8K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 21,800 | $8.61K | 0.00% | −93,322−81.1% | Reduced |
| Bank of New York Mellon Corp | 16,049 | $6.34K | 0.00% | −35−0.2% | Reduced |
| StoneX Group Inc. | 12,237 | $4.83K | 0.00% | +12,237 | New |
| Rathbone Brothers plc | 10,000 | $3.95K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 7,826 | $3.09K | 0.00% | −32,433−80.6% | Reduced |
| Royal Bank of Canada | 5,372 | $3.00K | 0.00% | −13−0.2% | Reduced |
| Bank of America Corp | 7,034 | $2.78K | 0.00% | +6,863+4,013.5% | Added |
| BNP Paribas Arbitrage, SA | 5,735 | $2.27K | 0.00% | +544+10.5% | Added |
| Belpointe Asset Management LLC | 5,500 | $2.17K | 0.00% | +5,500 | New |
| Barclays PLC | 5,321 | $2.10K | 0.00% | −1,926−26.6% | Reduced |
| Wells Fargo & Company | 761 | $300 | 0.00% | −1,484−66.1% | Reduced |
| Citigroup Inc | 737 | $291 | 0.00% | +36+5.1% | Added |
| Allworth Financial LP | 325 | $128 | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 50 | $20 | 0.00% | 00.0% | Unchanged |
| Pension & Wealth Management Advisors, Inc. | 10 | $4 | 0.00% | +10 | New |
| JPMorgan Chase & Co | 703 | $0 | 0.00% | −2,486−78.0% | Reduced |
| Umb Bank N A | 742 | $0 | 0.00% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,588,081−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −3,308,899−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,250,953−100.0% | Sold out |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −2,124,122−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −1,304,946−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −1,286,230−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −1,019,091−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −705,217−100.0% | Sold out |
| Palo Alto Investors LP | 0 | $0 | 0.00% | −432,300−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −320,000−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −171,729−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −130,756−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −20,414−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,954−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −12,173−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,671−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −8,264−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,648−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −570−100.0% | Sold out |
| Axiom Investment Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −551−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −106−100.0% | Sold out |